Urine protein (++++) requires further treatment because urine protein is a direct aggravating factor of kidney damage, and without active treatment, abnormal kidney function and even renal failure may occur. The most commonly used clinical drugs to lower urine protein are ACEI or ARB class, such as valsartan, irbesartan and benazepril. However, not all patients are better off with the above drugs alone. Some patients are caused by nephrotic syndrome, which is an immune system disease and requires active anti-immune therapy, and further renal puncture biopsy is recommended to clarify its pathological type. of the treatment plan. Therefore, according to the specific condition of the patient, choosing the appropriate treatment is the root of the treatment.